Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Return on Assets: 2021-2023

Historic Return on Assets for Cullinan Therapeutics (CGEM) over the last 2 years, with Sep 2023 value amounting to -0.31%.

  • Cullinan Therapeutics' Return on Assets fell 47.00% to -0.31% in Q3 2023 from the same period last year, while for Sep 2023 it was -0.31%, marking a year-over-year decrease of 47.00%. This contributed to the annual value of 0.22% for FY2022, which is 43.00% up from last year.
  • Cullinan Therapeutics' Return on Assets amounted to -0.31% in Q3 2023, which was down 12.24% from -0.27% recorded in Q2 2023.
  • Cullinan Therapeutics' 5-year Return on Assets high stood at 0.20% for Q2 2022, and its period low was -0.31% during Q3 2023.
  • For the 3-year period, Cullinan Therapeutics' Return on Assets averaged around -0.03%, with its median value being -0.02% (2021).
  • As far as peak fluctuations go, Cullinan Therapeutics' Return on Assets spiked by 34bps in 2022, and later plummeted by 47bps in 2023.
  • Over the past 3 years, Cullinan Therapeutics' Return on Assets (Quarterly) stood at -0.15% in 2021, then skyrocketed by 34bps to 0.19% in 2022, then slumped by 47bps to -0.31% in 2023.
  • Its Return on Assets stands at -0.31% for Q3 2023, versus -0.27% for Q2 2023 and 0.12% for Q1 2023.